Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease that is associated with severe uncontrolled eosinophilic asthma. Eosinophils play an important pathogenic role in the development of both diseases. Benralizumab is an antieosinophilic monoclonal antibody that binds to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Rivera, Carlos, Garcia-Olivé, Ignasi, Urrutia-Royo, Blanca, Basagaña-Torrento, Maria, Rosell, Antoni, Abad, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819231/
https://www.ncbi.nlm.nih.gov/pubmed/33478439
http://dx.doi.org/10.1186/s12890-021-01397-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819231/
https://www.ncbi.nlm.nih.gov/pubmed/33478439
http://dx.doi.org/10.1186/s12890-021-01397-7

Ejemplares similares